Survey to explore the willingness of future physicians and healthcare professionals

VACCELERATE has adapted a survey in an attempt to explore willingness of future physicians and healthcare professionals to contribute to advancements in healthcare by participating in COVID-19 vaccine trials. The objective is to understand the willingness of future healthcare professionals, across Europe, to participate in vaccine trials and provide valuable insights on the mindset of future physicians and healthcare providers.

To date over 600 responses have been recorded with Germany in the lead with 297 responses, followed by Sweden and then Cyprus. Understanding the willingness of this group will provide insights on the concerns and reluctance of participating in vaccine trials.

A press conference will be held on 29th September, 2023, to present the collective results gathered from a questionnaire designed by a collaboration between EUPATI Cyprus and European University Cyprus.

English version:

Exciting news from Switzerland! 

We're thrilled to announce our groundbreaking partnership with Working Bicycles, all while treading lightly on the ecological path. 🚴‍♂️ Pedaling Progress: Together for a greener world! At VACCELERATE, we are not just transforming lives and healthcare; we are doing it sustainably. Ready to be a part of this incredible journey?

Join us today at the Volunteer Registry and pedal your way to a brighter future! 


VACCELERATE Volunteer Registry boost in Sweden

The Swedish VACCELERATE team has had a busy time working to engage more individuals in vaccine research. With the aim of boosting the number of registrations in the VACCELERATE registry, an ambitious new communications campaign was rolled out. This targeted a wide spectrum of characteristics and focused on generating a registry of high quality. With the assistance of the CO in Cologne, new materials were designed and printed.

Multiple channels were harnessed, including social media, advertising in private vaccination clinics, and targeted outreach to universities and companies. The result was a more than 300% increase in registrations – from 70 to 231. 

Upcoming VACCELERATE Webinar 

Topic: VACCELERATE Arzt-Patient:innen Webinar Grippe? Corona? Wer sollte sich impfen lassen und wann? (in German)

Presenter: Prof. Joe Schmitt

Date: 17.10.2023, 19:00 CEST

Only for VACCELERATE Volunteers! More information following soon. 

We are very happy to announce that Module I of our Study Nurse Course is now online!

The course is designed for study/research nurses and will provide the needed expertise to conduct a clinical trial in line with the ICH GCP guidelines. Next to the regulatory background, the course also tackles and trains practical aspects necessary for the daily work of a study nurse. A well-trained trial centre is essential for the success of a clinical trial.

The total duration of the complete course (consisting of three modules) will provide learning material of about 30 hours (Module I: 9.5 hours). After each module, a certificate of completion can be downloaded.

More information:

On January 25th 2023 the VACCELERATE team from Cyprus joined a EUPATI ( meeting to support and enhance the role of patient advocacy groups in vaccine clinical research. They provided a gift with the VACCELERATE educational cards.

Do you have 10 minutes to help us prepare for the next COVID19 vaccine? Complete this anonymous online survey to help researchers better understand willingness to participate in vaccine clinicaltrials:

Current Project: VACCELERATE Survey on the frequency of viral respiratory diseases in Germany

COVID-19? RS virus? Or influenza? With the cold season, the number of respiratory diseases increases again. We are currently conducting a survey to determine the frequency and distribution of respiratory diseases.

For this purpose, volunteers from our Volunteer Registry are contacted and receive a test kit from us.

The test can detect 5 different viruses and is used if one or more of the following symptoms are present for at least 24 hours: Cough, sore throat, runny nose, difficulty breathing, redness of the eyes, loss of smell or taste and also aching limbs with or without fever.

The test result is reported to the VACCELERATE team by email and evaluated.


Aktuelles Projekt: VACCELERATE Erhebung zur Häufigkeit von viralen Atemwegserkrankungen in Deutschland

COVID-19? RS-Virus? Oder doch Influenza? Mit der kalten Jahreszeit steigt auch die Anzahl von Atemwegserkrankungen wieder an. Aktuell führen wir eine Untersuchung durch, um die Häufigkeit und Verteilung dieser Atemwegserkrankungen in Deutschland festzustellen.

Dazu schreiben wir bei uns registrierte Teilnehmerinnen und Teilnehmer an und senden Interessierten ein Test-Kit zu.

Der Test kann 5 verschiedene Viren nachweisen und sollte durchgeführt werden, wenn für mindestens 24 Stunden Symptome bestehen wie Husten, Halsschmerzen, Schnupfen, Atembeschwerden, Augenrötung, Geruchs- oder Geschmacksverlust oder Gliederschmerzen mit oder ohne Fieber.

Das Testergebnis wird dann dem VACCELERATE Team per E-Mail mitgeteilt und ausgewertet.

New Scientific VACCELERATE Publication

08.10.2022 / A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network (Trials):

Upcoming VACCELERATE Webinar

Topic: eConsent – Chances and Challenges for a Multistakeholder Community

Presenter: Hilde Vanaken, PhD

Date: 05.07.2023, 14:00 CEST



We are happy to send you the pdf versions of our newsletters including the links providing further information on the topics: 


Published in September 2023.


Published in June 2023.


Published in March 2023.


Published in December 2022. 


Published in September 2022. 


Published in July 2022. 

VACCELERATE Press Releases

12.01.2023 / Would You Take Part in A Clinical Vaccine Trial? A Survey on COVID-19 Vaccine Trial Participation by the EU-funded project VACCELERATE: Willingness to participate in COVID-19 vaccine trials (

19.09.2022 / VACCELERATE Network Supports Diagnostics and Treatment of Monkeypox:

29.08.2022 / Lietuvoje jau veikia VACCELERATE savanorių dalyvauti klinikiniuose tyrimuose registras:

25.08.2022 / First children participate in UMC Utrecht-led study: Is one COVID-19 vaccination dose enough for kids?

28.07.2022 / The VACCELERATE Volunteer Clinical Trial Registry is launched in Italy:

21.07.2022 / How many COVID-19 infections are there in Germany? Pilot study in Cologne investigates high dark figure: (German translation:

15.03.2022 / VACCELERATE study on the effectiveness of a second booster shot begins in Ireland:

22.02.2022 / Karolinska Universitetssjukhuset söker fler deltagare i kampen mot framtida pandemier: Karolinska Universitetssjukhuset söker fler deltagare i kampen mot framtida pandemier – Karolinska Universitetssjukhuset (

16.02.2022 / Wer sollte wann weiteren Booster bekommen?:

05.11.2021 / Studie zur Wirksamkeit der „Boosterimpfung“ gegen Corona startet:

22.07.2021 / Coronavirus: Commission steps up research funding with €120 million for 11 new projects to tackle the virus and its variants (European Commission):

12.04.2021 / Cologne’s university medicine to coordinate EU vaccine research network (Coimbra Group):

16.03.2021 COMBACTE To Support Vaccine Trial Network VACCELERATE (Combacte):

15.03.2021 / 12 Million for European COVID-19 Vaccine Research (Combacte):

18.02.2021 / Neues Konsortium koordiniert EU-Impfstoff-Forschungsnetzwerk:

18.02.2021 / Cologne’s university medicine to coordinate EU vaccine research network VACCELERATE (CECAD):

17.02.2021 / EU to invest €150 million for research to counter coronavirus variants (European Commission):



23.12.2022 / Johanna Massy (64) is 50.000ste vrijwilliger bij Vaccinopolis: “Door deel te nemen hoop ik de wetenschap vooruit te helpen” (HLN):

23.11.2022 / Výzkumná síť VACCELERATE: staňte se součástí výzva registru dobrovolníků (MUNI MED):

10.10.2022 / Corona-Pandemie wurde zum Booster für Vakzinologie (K.AT News):

20.09.2022 / Η Ελλάδα στον χάρτη των κλινικών δοκιμών εμβολίων κατά της CoViD (Iatronet):

28.07.2022 / Nasce in Italia „VACCELERATE“, il registro degli studi clinici volontari: Verona è capofila nazionale (Mattino Verona):

28.07.2022 / Partecipare a studi su prodotti anti-pandemie, al via registro volontari (Lafreccia):

28.07.2022 / Nasce in Italia „VACCELERATE“, il registro degli studi clinici volontari: Verona è capofila nazionale (In salute news):

28.07.2022 / Covid: attivo in Italia registro volontari „VACCELERATE“ Database permette di aderire a progretti sul vaccino (Federfarma):

28.07.2022 / Partecipare a studi su prodotti anti-pandemie, al via registro volontari (Corriere Del Umbria):

28.07.2022 / L'università di Verona riferimento nazionale del Registro degli studi clinici volontari „VACCELERATE“ (Primoweb):

28.07.2022 / Arriva in Italia registro die volontari per participare a studi clinici sui vaccini (Veronasera):

28.07.2022 / Partecipare a studi su prodotti anti-pandemie, al via registro volontari (Olbia Notizie):

28.07.2022 / Partecipare a studi su prodotti anti-pandemie, al via registro volontari (Tiscali News):

28.07.2022 / Partecipare a studi su prodotti anti-pandemie, al via registro volontari (Affaritaliani):

28.07.2022 / Nasce in Italia „VACCELERATE“, il registro degli studi clinici volontari: Verona è capofila nazionale (A Salute & Benessere):

26.07.2022 / UMC Utrecht is investigating whether one corona jab in children works just as well as two (Time.News):

26.07.2022 / Onderzoek naar 1 of 2 coronaprikken bij kinderen (UMC Utrecht):

27.03.2022 / Antibodies could determine fourth vaccine eligibility – study:

24.01.2022 / VACCELERATE: Volunteer Registry: A European Study Participant Database to Facilitate Clinical Trial Enrolment (THE LANCET Preprint):

06.01.2022 / Nach dem Booster: Brauchen wir bald noch eine vierte Impfung gegen Corona? (Kölner Stadt-Anzeiger):–39359316

19.12.2021 / Die Vierte Impfung. Impfstoff gegen Omikron (Zeit):

13.12.2021 / Mehrere Impfversuche bei initialen Non-Respondern machen“ (Ärzteblatt):

08.12.2021 / Interview with Zoi D. Pana about the situation in Cyprus and the VACCELERATE network (Offsite):

03.12.2021 / Interview with Oliver Cornely and Zoi D. Pana (Alpha Channel CY):

23.11.2021 / Interview „Seit März 2020 im Lockdown“ (Kölner Stadt-Anzeiger): Print

15.11.2021 / Lietuvoje pradėtas COVID-19 stiprinamosios vakcinos dozės tyrimas (Lrytas):

15.11.2021 / Pradėtas COVID-19 stiprinamosios vakcinos dozės tyrimas (Santaros Klinikos):

12.11.2021 / Studie untersucht Booster-Effekt (Kölnische Rundschau): Print

12.11.2021 / Uni Köln Studie untersucht Booster-Effekt der Corona-Impfungen (Kölnische Rundschau): Uni Köln: Studie untersucht Booster-Effekt der Corona-Impfungen | Kölnische Rundschau (

09.11.2021 / Studie zur Wirksamkeit der Booster-Impfung (Frankfurt Live):

08.11.2021 /Neue Studie startet in Köln Wie gut sind Booster-Impfungen wirklich? (Kölner Stadt-Anzeiger):–39112684

03.11.2021 / Alle Infos zur Auffrischung Wann kann ich mir die Booster-Impfung gegen Corona holen? (Kölner Stadt-Anzeiger): Booster-Impfung: Wer braucht die dritte Impfdosis? | Kölner Stadt-Anzeiger (

26.10.2021 / Nach Kimmich-Aussage Was Experten zu Langzeitfolgen der Corona-Impfung sagen (Kölner Stadt-Anzeiger):

25.10.2021 / Uniklinik Köln sucht Probanden für Drittimpfung (WDR): TV

13.10.2021 / Studie zur Wirksamkeit der Booster-Impfung (Radio Köln): Radio

28.09.2021 / Zu langsam, zu mühsam, zu wenig (SZ): Print

27.09.2021 / Der geringe Beitrag der deutschen COVID-19-Forschung (Tagesspiegel): Print 

16.07.2021 / ECCMID 2021 TV: Talking trials with Oliver Cornely (ECCMID TV):

10.07.2021 / Hunderte Kölner trotz zweiter Impfung infiziert (Kölner Stadt-Anzeiger): Print

09.07.2021 / Zu wenig Antikörper? Was wir über die COVID-19-Todesfälle bei geimpften Kölnern wissen? (Kölner Stadt-Anzeiger)

30.06.2021 / Coronavirus: Government advisor part of €12m grant for Covid vaccine research (Cyprus Mail):

27.05.2021 / Aufholjagd: Das europäische Impfstoff-Netzwerk Vaccelerate (ARTE):

12.05.2021 / Expert says at least one booster vaccine shot necessary (in-Cyprus):

11.04.2021 / Pulse of Europe Rheinland: „Europa – Gesundheitspolitik für eine krisenfeste Zukunft?“ (Event):

14.03.2021 / 11.111 – VACCELERATE Volunteer Registry (Kölner Universitätsmagazin):



VACCELERATE-related Scientific Publications

01.09.2023 / Factors that impact on recruitment to vaccine trials in the context of a pandemic or epidemic: a qualitative evidence synthesis (Cochrane Library):

18.05.2023 / VACCELERATE Site Network: Real-time definition of clinical study capacity in Europe (Vaccine):

03.04.2023 / Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit (JMIR Publications):

07.12.2022 / Efficacy and safety of COVID‐19 vaccines (Cochrane Library):

11.2022 / Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccination (Journal of Immunological Methods):

10.2022 / Monkeypox diagnostic and treatment capacity at epidemic onset: A VACCELERATE online survey (Journal of Infection and Public Health):

08.10.2022 / A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network (Trials):

04.10.2022 / Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2 (eBioMedicine):

19.09.2022 / Monkeypox in children and adult women in Europe: Results from a flash VACCELERATE pilot survey (Enfermedades Infecciosas y Microbiología Clínica):

31.08.2022 / Vaccination rates in Europe are not associated with online media intensity (JCOM Journal of Science Communication):

18.06.2022 / A pilot surveillance report of SARS-CoV-2 rapid antigen test results among volunteers in Germany, 1st week of July 2022 (Infection):

13.06.2022 / Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR (Nature Biotechnology):

02.06.2022 / VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment (Vaccine):

05.04.2022 / A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern (Communications Medicine):

23.03.2022 / Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination (Frontiers in Immunology):

11.01.2022 / Factors that impact on recruitment to vaccine trials during a pandemic or epidemic: a qualitative evidence synthesis (Cochrane Library):

04.10.2021 / Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days (Frontiers in Immunology):

03.08.2021 / Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals (Cell Reports):

29.07.2021 / Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 (The Lancet Infectious Diseases):

27.05.2021 / Reactogenicity and Immunogenicity of BNT162b2 in Subjects Having Received a First Dose of ChAdOx1s: Initial Results of a Randomised, Adaptive, Phase 2 Trial (CombiVacS) (The Lancet):



KIT 2023 / VACCELERATE Talks and Posters

14-17 June 2023

16th Congress for Infectious Diseases and Tropical Medicine
Leipzig, Germany

Pint of Science / VACCELERATE Talk 

24 May 2023, 19.00 Die Tankstelle, Kyffhäuser Str. 19 50674, Cologne

Tickets (only 2.5€):

SCT 44th Annual Meeting

21-24 May 2023 Baltimore, USA

Public Health Conference Timisoara, Romania

11-13 May 2023

Organized by the Regional Center of Public Health Timisoara, EPIVEST Association and the University of Medicine and Pharmacy Timisoara.

The conference targeted public health specialists from the regional public health authorities, medical schools and hospitals.

CECAD Open Day

06 May 2023, 10.00-17.00

Visit our VACCELERATE booth, special campagin with the Vacuna vaccination app (



33rd European Congress of Clinical Microbiology & Infectious Diseases

 15 – 18 April 2023 Copenhagen, Denmark

11. Deutsch-Österreichischen-AIDS-Kongress (DÖAK 2023) 
23-25 March 2023 Bonn, Germany

2nd VACCELERATE Annual Meeting 16 MARCH 2023

1st Scientific Meeting of the National CY Vaccination Committee 

22 October 2022, Cyprus

MYK 2022

12-14 September 2022 Vienna, Austria

CZECRIN Annual Research Conference 2022 

09 JUNE 2022 Brno, Czech Republic

International Clinical Trials Day (ICTD) 2022

17 MAY 2022 Berlin, Germany

FAMHP Vaccine Symposium

10 May 2022

Prof. Pierre Van Damme presenting VACCELERATE in his talk „Perspective for the future: Vaccinopolis and biopreparedness initiative“

40th Annual Meeting of the European Society of Paediatric Infectious Diseases (ESPID) 

09-13 MAY 2022 Athens, Greece

World Vaccine Day 14 MAY 2022

On World Vaccine Day people around the world celebrate the benefits of vaccines. This day aims to raise awareness of the many positive contributions that vaccines make to our society. 

More information on

23-26 APRIL 2022

32nd European Congress of Clinical Microbiology & Infectious Diseases, Lisbon, Portugal

1st Cypriot-Greek VACCELERATE Volunteer Registry Webinar with local National Patient Advocacy Groups 28 MARCH 2022

– To seek the support of PAG Members in completing the VAC PAG questionnaire (perspectives of PAGs for participation in clinical trials and volunteer registries)

– To invite them to join the VACCELERATE Volunteer Registry by becoming volunteers in our Cypriot Greek VAC platforms More than 12 PAGs participated

You can watch the video of the webinar (in Greek) here:

The First World Conference Fighting COVID-19 Pandemic Health Challenges

26-28 MARCH 2022, Belgrade, Serbia.

VACCELERATE talk: Jon Salmanton-García: VACCELERATE: The pan-European backbone for the acceleration of phase 2 & 3 COVID-19 vaccine trials

1st VACCELERATE Annual Meeting 09-10 MARCH 2022

With a keynote lecture by top leading expert Stephen Lockhart  from Pfizer:
Vaccine Clinical Trials: Key Factors for Success – BNT162 as an Example.